NIR-labeled nanoparticles engineered for brain targeting: In vivo optical imaging application and fluorescent microscopy evidences

G. Tosi, L. Bondioli, B. Ruozi, L. Badiali, G. M. Severini, S. Biffi, A. De Vita, B. Bortot, D. Dolcetta, F. Forni, M. A. Vandelli

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The presence of the blood-brain barrier (BBB) makes extremely difficult to develop efficacious strategies for targeting contrast agents and delivering drugs inside the Central Nervous System (CNS). To overcome this drawback, several kinds of CNS-targeted nanoparticles (NPs) have been developed. In particular, we proposed poly-lactide-co-glycolide (PLGA) NPs engineered with a simil-opioid glycopeptide (g7), which have already proved to be a promising tool for achieving a successful brain targeting after i.v. administration in rats. In order to obtain CNS-targeted NPs to use for in vivo imaging, we synthesized and administrated in mice PLGA NPs with double coverage: near-infrared (NIR) probe (DY-675) and g 7. The optical imaging clearly showed a brain localization of these novel NPs. Thus, a novel kind of NIR-labeled NPs were obtained, providing a new, in vivo detectable nanotechnology tool. Besides, the confocal and fluorescence microscopy evidences allowed to further confirm the ability of g 7 to promote not only the rat, but also the mouse BBB crossing.

Original languageEnglish
Pages (from-to)145-153
Number of pages9
JournalJournal of Neural Transmission
Volume118
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Optical Imaging
Nanoparticles
Microscopy
Brain
Blood-Brain Barrier
Central Nervous System
Central Nervous System Agents
Polyglactin 910
Nanotechnology
Glycopeptides
Fluorescence Microscopy
Confocal Microscopy
Contrast Media
Opioid Analgesics

Keywords

  • Brain targeting
  • Confocal and fluorescence microscopy
  • Nanoparticles
  • NIR
  • Optical imaging

ASJC Scopus subject areas

  • Biological Psychiatry
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

NIR-labeled nanoparticles engineered for brain targeting : In vivo optical imaging application and fluorescent microscopy evidences. / Tosi, G.; Bondioli, L.; Ruozi, B.; Badiali, L.; Severini, G. M.; Biffi, S.; De Vita, A.; Bortot, B.; Dolcetta, D.; Forni, F.; Vandelli, M. A.

In: Journal of Neural Transmission, Vol. 118, No. 1, 01.2011, p. 145-153.

Research output: Contribution to journalArticle

Tosi, G. ; Bondioli, L. ; Ruozi, B. ; Badiali, L. ; Severini, G. M. ; Biffi, S. ; De Vita, A. ; Bortot, B. ; Dolcetta, D. ; Forni, F. ; Vandelli, M. A. / NIR-labeled nanoparticles engineered for brain targeting : In vivo optical imaging application and fluorescent microscopy evidences. In: Journal of Neural Transmission. 2011 ; Vol. 118, No. 1. pp. 145-153.
@article{144be0e925534b32ad12fb8523b834c0,
title = "NIR-labeled nanoparticles engineered for brain targeting: In vivo optical imaging application and fluorescent microscopy evidences",
abstract = "The presence of the blood-brain barrier (BBB) makes extremely difficult to develop efficacious strategies for targeting contrast agents and delivering drugs inside the Central Nervous System (CNS). To overcome this drawback, several kinds of CNS-targeted nanoparticles (NPs) have been developed. In particular, we proposed poly-lactide-co-glycolide (PLGA) NPs engineered with a simil-opioid glycopeptide (g7), which have already proved to be a promising tool for achieving a successful brain targeting after i.v. administration in rats. In order to obtain CNS-targeted NPs to use for in vivo imaging, we synthesized and administrated in mice PLGA NPs with double coverage: near-infrared (NIR) probe (DY-675) and g 7. The optical imaging clearly showed a brain localization of these novel NPs. Thus, a novel kind of NIR-labeled NPs were obtained, providing a new, in vivo detectable nanotechnology tool. Besides, the confocal and fluorescence microscopy evidences allowed to further confirm the ability of g 7 to promote not only the rat, but also the mouse BBB crossing.",
keywords = "Brain targeting, Confocal and fluorescence microscopy, Nanoparticles, NIR, Optical imaging",
author = "G. Tosi and L. Bondioli and B. Ruozi and L. Badiali and Severini, {G. M.} and S. Biffi and {De Vita}, A. and B. Bortot and D. Dolcetta and F. Forni and Vandelli, {M. A.}",
year = "2011",
month = "1",
doi = "10.1007/s00702-010-0497-1",
language = "English",
volume = "118",
pages = "145--153",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer-Verlag Wien",
number = "1",

}

TY - JOUR

T1 - NIR-labeled nanoparticles engineered for brain targeting

T2 - In vivo optical imaging application and fluorescent microscopy evidences

AU - Tosi, G.

AU - Bondioli, L.

AU - Ruozi, B.

AU - Badiali, L.

AU - Severini, G. M.

AU - Biffi, S.

AU - De Vita, A.

AU - Bortot, B.

AU - Dolcetta, D.

AU - Forni, F.

AU - Vandelli, M. A.

PY - 2011/1

Y1 - 2011/1

N2 - The presence of the blood-brain barrier (BBB) makes extremely difficult to develop efficacious strategies for targeting contrast agents and delivering drugs inside the Central Nervous System (CNS). To overcome this drawback, several kinds of CNS-targeted nanoparticles (NPs) have been developed. In particular, we proposed poly-lactide-co-glycolide (PLGA) NPs engineered with a simil-opioid glycopeptide (g7), which have already proved to be a promising tool for achieving a successful brain targeting after i.v. administration in rats. In order to obtain CNS-targeted NPs to use for in vivo imaging, we synthesized and administrated in mice PLGA NPs with double coverage: near-infrared (NIR) probe (DY-675) and g 7. The optical imaging clearly showed a brain localization of these novel NPs. Thus, a novel kind of NIR-labeled NPs were obtained, providing a new, in vivo detectable nanotechnology tool. Besides, the confocal and fluorescence microscopy evidences allowed to further confirm the ability of g 7 to promote not only the rat, but also the mouse BBB crossing.

AB - The presence of the blood-brain barrier (BBB) makes extremely difficult to develop efficacious strategies for targeting contrast agents and delivering drugs inside the Central Nervous System (CNS). To overcome this drawback, several kinds of CNS-targeted nanoparticles (NPs) have been developed. In particular, we proposed poly-lactide-co-glycolide (PLGA) NPs engineered with a simil-opioid glycopeptide (g7), which have already proved to be a promising tool for achieving a successful brain targeting after i.v. administration in rats. In order to obtain CNS-targeted NPs to use for in vivo imaging, we synthesized and administrated in mice PLGA NPs with double coverage: near-infrared (NIR) probe (DY-675) and g 7. The optical imaging clearly showed a brain localization of these novel NPs. Thus, a novel kind of NIR-labeled NPs were obtained, providing a new, in vivo detectable nanotechnology tool. Besides, the confocal and fluorescence microscopy evidences allowed to further confirm the ability of g 7 to promote not only the rat, but also the mouse BBB crossing.

KW - Brain targeting

KW - Confocal and fluorescence microscopy

KW - Nanoparticles

KW - NIR

KW - Optical imaging

UR - http://www.scopus.com/inward/record.url?scp=79951676874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951676874&partnerID=8YFLogxK

U2 - 10.1007/s00702-010-0497-1

DO - 10.1007/s00702-010-0497-1

M3 - Article

C2 - 20931242

AN - SCOPUS:79951676874

VL - 118

SP - 145

EP - 153

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - 1

ER -